CA1202581A
(en)
*
|
1980-03-27 |
1986-04-01 |
Saran A. Narang |
Adaptor molecules for dna and their application to synthesis of gene-derived products
|
ATE56471T1
(de)
|
1980-04-03 |
1990-09-15 |
Biogen Inc |
Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
|
US4874702A
(en)
*
|
1980-09-08 |
1989-10-17 |
Biogen, Inc. |
Vectors and methods for making such vectors and for expressive cloned genes
|
DK489481A
(da)
*
|
1980-11-10 |
1982-05-11 |
Searle & Co |
Plasmidvektor og frmgangsmaade til fremstilling deraf
|
US5525484A
(en)
*
|
1981-01-16 |
1996-06-11 |
Genome Therapeutics Corp. |
Recombinant DNA means and method for producing rennin, prorenin and pre-prorennin
|
BR8205954A
(pt)
*
|
1981-10-14 |
1983-09-13 |
Unilever Nv |
Sequencia de dna,plasmidio recombinante,cultura bacteriana e microorganismos
|
JPS58110600A
(ja)
*
|
1981-12-25 |
1983-07-01 |
Kyowa Hakko Kogyo Co Ltd |
ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
|
JPS58141796A
(ja)
*
|
1982-02-18 |
1983-08-23 |
Kyowa Hakko Kogyo Co Ltd |
ペプチドの製造法
|
DE3382317D1
(de)
*
|
1982-03-15 |
1991-07-25 |
Schering Corp |
Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
|
US4499188A
(en)
*
|
1982-05-05 |
1985-02-12 |
Cetus Corporation |
Bacterial production of heterologous polypeptides under the control of a repressible promoter-operator
|
US4863855A
(en)
*
|
1982-05-14 |
1989-09-05 |
The Research Foundation Of State University Of New York |
Novel cloning vehicles for polypeptide expression in microbial hosts
|
DE3378638D1
(de)
*
|
1982-10-25 |
1989-01-12 |
Monsanto Co |
Reca promoter dependent polypeptide production
|
CA1252046A
(en)
*
|
1982-11-04 |
1989-04-04 |
Martin J. Cline |
Methods for oncogenic detection
|
DE3247922A1
(de)
*
|
1982-12-24 |
1984-06-28 |
Boehringer Ingelheim International GmbH, 6507 Ingelheim |
Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
|
DK161152C
(da)
|
1983-03-03 |
1991-11-11 |
Genentech Inc |
Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
|
US5169762A
(en)
*
|
1983-03-03 |
1992-12-08 |
Genentech, Inc. |
Human nerve growth factor by recombinant technology
|
US4701416A
(en)
*
|
1983-12-09 |
1987-10-20 |
Cetus Corporation |
Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
|
US4935370A
(en)
*
|
1983-12-23 |
1990-06-19 |
Pfizer Inc. |
Expression plasmids for improved production of heterologous protein in bacteria
|
EP0172194B1
(en)
*
|
1984-02-08 |
1994-01-19 |
Cetus Oncology Corporation |
Control systems for recombinant manipulations
|
GB8407044D0
(en)
*
|
1984-03-19 |
1984-04-26 |
Fujisawa Pharmaceutical Co |
Producing human insulin
|
US5028531A
(en)
*
|
1984-03-19 |
1991-07-02 |
Fujisawa Pharmaceutical Company, Ltd. |
IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
|
US4656132A
(en)
|
1984-03-28 |
1987-04-07 |
Cetus Corporation |
Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
|
US4894334A
(en)
*
|
1984-03-28 |
1990-01-16 |
Cetus Corporation |
Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
|
US5268278A
(en)
*
|
1984-03-30 |
1993-12-07 |
Istituto Farmacologico Serono S.P.A. |
Genetic expression of somatostatin as hybrid polypeptide
|
US4789702A
(en)
*
|
1984-05-18 |
1988-12-06 |
Cetus Corporation |
Feline leukemia virus vaccine
|
US5683688A
(en)
|
1984-05-31 |
1997-11-04 |
Genentech, Inc. |
Unglycosylated recombinant human lymphotoxin polypeptides and compositions
|
EP0165613B1
(en)
*
|
1984-06-22 |
1992-01-15 |
Hitachi, Ltd. |
Process for controlling culture of recombinants
|
JPS619282A
(ja)
*
|
1984-06-22 |
1986-01-16 |
Hitachi Ltd |
遺伝子組換え菌の培養方法
|
EP0178764A1
(en)
*
|
1984-08-28 |
1986-04-23 |
Genex Corporation |
Method of stabilizing a host microorganism/expression vector system for large scale production of proteins
|
US4738921A
(en)
*
|
1984-09-27 |
1988-04-19 |
Eli Lilly And Company |
Derivative of the tryptophan operon for expression of fused gene products
|
US5075224A
(en)
*
|
1984-10-19 |
1991-12-24 |
Genentech, Inc. |
Prepro-LHRH C-terminal peptide DNA
|
NZ213759A
(en)
*
|
1984-10-19 |
1989-01-27 |
Genentech Inc |
Lhrh-ctp protein conjugates influencing prolactin fsh and lh release
|
FI90990C
(fi)
*
|
1984-12-18 |
1994-04-25 |
Boehringer Ingelheim Int |
Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
|
KR870700095A
(ko)
|
1985-01-28 |
1987-02-28 |
원본미기재 |
AraB 프로모터 및 미생물학적 방법에 의해 세크로핀을 포함한 폴리펩타이드를 제조하는 방법
|
IT1234977B
(it)
*
|
1985-03-22 |
1992-06-09 |
Serono Ist Farm |
Espressione in e. coli polipeptidi ibridi contenenti la sequenza del fattore di rilascio dell'ormone della crescita
|
US4683202A
(en)
*
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
ES8706823A1
(es)
*
|
1985-03-28 |
1987-06-16 |
Cetus Corp |
Un procedimiento para detectar la presencia o ausencia de al menos una secuencia especifica de acidos nucleicos en una muestra
|
US4965188A
(en)
*
|
1986-08-22 |
1990-10-23 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
|
GB8509289D0
(en)
*
|
1985-04-11 |
1985-05-15 |
Fujisawa Pharmaceutical Co |
Production of somatostatin
|
DE3526995A1
(de)
*
|
1985-07-27 |
1987-02-05 |
Hoechst Ag |
Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung
|
ES2000859A6
(es)
*
|
1985-08-12 |
1988-03-16 |
Syntex Inc |
Un metodo para producir un vector de expresion bacteriana para la expresion de proteinas de fusion
|
EP0213472A1
(en)
*
|
1985-08-12 |
1987-03-11 |
Syntex (U.S.A.) Inc. |
Method for producing fusion proteins
|
JPH0775536B2
(ja)
*
|
1986-03-26 |
1995-08-16 |
猛 小林 |
遺伝子組み換え菌を用いた酵素生産装置
|
DE3642096A1
(de)
*
|
1986-12-10 |
1988-06-16 |
Boehringer Ingelheim Int |
Pferde-(gamma)-interferon
|
US6994988B1
(en)
|
1987-02-12 |
2006-02-07 |
Genetech, Inc. |
Methods and deoxyribonucleic acid for the preparation of tissue factor protein
|
JPH01247099A
(ja)
*
|
1988-03-30 |
1989-10-02 |
Hitachi Ltd |
ヒトの上皮細胞増殖因子の遺伝子工学的生産方法
|
JPH01247098A
(ja)
*
|
1988-03-30 |
1989-10-02 |
Hitachi Ltd |
ヒトの上皮細胞増殖因子の遺伝子工学的生産方法
|
EP0335400B1
(en)
*
|
1988-03-30 |
1994-06-08 |
Hitachi, Ltd. |
Processes for production of human epidermal growth factor by genetic engineering
|
JPH0227993A
(ja)
*
|
1988-07-15 |
1990-01-30 |
Nippon Shinyaku Co Ltd |
hEGFの製法
|
IL92937A0
(en)
|
1989-01-31 |
1990-09-17 |
Us Health |
Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
ATE158816T1
(de)
|
1990-11-26 |
1997-10-15 |
Genetics Inst |
Expression von pace in wirtszellen und verfahren zu dessen verwendung
|
AU664469B2
(en)
|
1992-06-03 |
1995-11-16 |
Genentech Inc. |
Tissue plasminogen activator glycosylation variants with improved therapeutic properties
|
GB9325182D0
(en)
*
|
1993-12-08 |
1994-02-09 |
T Cell Sciences Inc |
Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
|
US6001604A
(en)
*
|
1993-12-29 |
1999-12-14 |
Bio-Technology General Corp. |
Refolding of proinsulins without addition of reducing agents
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
US6455304B1
(en)
|
1994-07-01 |
2002-09-24 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronate synthase gene and uses thereof
|
US6951743B2
(en)
|
1997-10-31 |
2005-10-04 |
University Of Oklahoma Board Of Regents |
Hyaluronan synthase genes and expression thereof in bacillus hosts
|
US7091008B1
(en)
|
1994-07-01 |
2006-08-15 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthase genes and expression thereof in Bacillus hosts
|
US6077510A
(en)
*
|
1995-01-06 |
2000-06-20 |
Regents Of The University Of California |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
|
US6113905A
(en)
*
|
1995-01-06 |
2000-09-05 |
The Regents Of The University Of California |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
|
US6015660A
(en)
*
|
1995-01-06 |
2000-01-18 |
The Regents Of The University Of California |
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
|
US5795966A
(en)
|
1995-02-22 |
1998-08-18 |
Immunex Corp |
Antagonists of interleukin-15
|
KR100510234B1
(ko)
|
1995-06-29 |
2005-11-25 |
임뮤넥스 코포레이션 |
세포소멸을 유도하는 시토킨
|
US6020473A
(en)
*
|
1995-08-25 |
2000-02-01 |
Genentech, Inc. |
Nucleic acids encoding variants of vascular endothelial cell growth factor
|
US7005505B1
(en)
|
1995-08-25 |
2006-02-28 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor
|
US6030945A
(en)
*
|
1996-01-09 |
2000-02-29 |
Genentech, Inc. |
Apo-2 ligand
|
US6998116B1
(en)
|
1996-01-09 |
2006-02-14 |
Genentech, Inc. |
Apo-2 ligand
|
US6469144B1
(en)
|
1996-04-01 |
2002-10-22 |
Genentech, Inc. |
Apo-2LI and Apo-3 polypeptides
|
US6100071A
(en)
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
US5851984A
(en)
*
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
US6159462A
(en)
*
|
1996-08-16 |
2000-12-12 |
Genentech, Inc. |
Uses of Wnt polypeptides
|
US6462176B1
(en)
|
1996-09-23 |
2002-10-08 |
Genentech, Inc. |
Apo-3 polypeptide
|
US5990281A
(en)
*
|
1996-09-30 |
1999-11-23 |
Genentech, Inc. |
Vertebrate smoothened proteins
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
DE69740107D1
(de)
|
1996-12-23 |
2011-03-10 |
Immunex Corp |
Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie
|
CA2286326C
(en)
*
|
1997-04-04 |
2007-06-26 |
Adam L. Cohen |
Article, method, and apparatus for electrochemical fabrication
|
US6448035B1
(en)
|
1997-04-24 |
2002-09-10 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR)
|
US6384203B1
(en)
|
1999-05-12 |
2002-05-07 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
|
US6342369B1
(en)
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
CA2293724C
(en)
|
1997-06-05 |
2010-02-02 |
Xiaodong Wang |
Apaf-1, the ced-4 human homolog, an activator of caspase-3
|
JP2002508663A
(ja)
|
1997-06-18 |
2002-03-19 |
ジェネンテク,インコーポレイテッド |
Apo−2DcR
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
US6030619A
(en)
|
1997-08-27 |
2000-02-29 |
Chiron Corporation |
Molecular mimetics of meningococcal B epitopes
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
DE69839401T2
(de)
|
1997-09-18 |
2009-05-07 |
Genentech Inc., San Francisco |
Dcr3 polypeptid, ein tnfr homolog
|
IL135051A0
(en)
|
1997-10-10 |
2001-05-20 |
Genentech Inc |
Apo-3 ligand polypeptide
|
CA2306183A1
(en)
|
1997-10-29 |
1999-05-06 |
Genentech, Inc. |
Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
|
IL135607A0
(en)
|
1997-10-29 |
2001-05-20 |
Genentech Inc |
Wnt-1 inducible genes
|
KR20010031682A
(ko)
|
1997-10-31 |
2001-04-16 |
존 팔머 |
히알우로난 합성효소 유전자 및 그의 용도
|
CN101113436B
(zh)
|
1997-10-31 |
2013-02-06 |
俄克拉何马大学董事会 |
透明质酸合酶基因及其应用
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
ATE410512T1
(de)
|
1997-11-21 |
2008-10-15 |
Genentech Inc |
Plättchen-spezifische antigene und deren pharmazeutische verwendung
|
EP2278011A3
(en)
|
1998-01-14 |
2012-03-07 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisseria meningitidis antigens
|
WO1999036535A1
(en)
|
1998-01-15 |
1999-07-22 |
Genentech, Inc. |
Apo-2 ligand
|
US6727079B1
(en)
|
1998-02-25 |
2004-04-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product
|
NZ525914A
(en)
|
1998-03-10 |
2004-03-26 |
Genentech Inc |
Novel polypeptides and nucleic acids encoding the same
|
DK1064382T3
(da)
|
1998-03-17 |
2008-12-08 |
Genentech Inc |
Homologe polypeptider til VEGF og BMP1
|
US20060188966A1
(en)
|
1998-04-02 |
2006-08-24 |
Deangelis Paul L |
Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
|
US7223571B2
(en)
|
1998-04-02 |
2007-05-29 |
The Board Of Regents Of The Universtiy Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
US6987023B2
(en)
|
1998-04-02 |
2006-01-17 |
The Board Of Regents Of The University Of Oklahoma |
DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
AU761780B2
(en)
|
1998-05-01 |
2003-06-12 |
Glaxosmithkline Biologicals Sa |
Neisseria meningitidis antigens and compositions
|
EP3112468A1
(en)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
PT1076703E
(pt)
|
1998-05-15 |
2007-10-10 |
Genentech Inc |
''utilizações terapêuticas de polipéptido homólogos de il-17''
|
EP1865061A3
(en)
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
DK1105485T3
(da)
|
1998-08-21 |
2006-10-30 |
Immunex Corp |
Human IL-1-epsilon-DNA og polypeptider
|
EP1109928A4
(en)
|
1998-09-03 |
2004-10-13 |
Bristol Myers Squibb Co |
OXIDATIVE ENZYMATIC DEAMINATION PROCESS
|
JP2002527066A
(ja)
|
1998-10-15 |
2002-08-27 |
カイロン コーポレイション |
転移性乳癌および結腸癌調節遺伝子
|
US7094581B2
(en)
|
1998-10-26 |
2006-08-22 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthases and methods of making and using same
|
PT1141331E
(pt)
|
1998-12-16 |
2008-12-22 |
Novartis Vaccines & Diagnostic |
Quinase dependente de ciclina humana (hpnqalre)
|
CA2450402A1
(en)
|
1998-12-22 |
2000-06-29 |
Genentech, Inc. |
Methods and compositions for inhibiting cancer cell growth comprising pro224
|
EP2330198A1
(en)
|
1998-12-23 |
2011-06-08 |
Genentech, Inc. |
IL-1 related polypeptides
|
EP1228217B1
(en)
|
1999-04-30 |
2012-11-21 |
Novartis Vaccines and Diagnostics S.r.l. |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
EP1978029A3
(en)
|
1999-06-15 |
2008-10-15 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids endoding the same
|
US7101989B1
(en)
|
1999-07-09 |
2006-09-05 |
University Of North Carolina At Chapel Hill |
DsrA protein and polynucleotides encoding the same
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
AU783767B2
(en)
|
1999-10-14 |
2005-12-01 |
Takara Bio Usa, Inc. |
Anthozoa derived chromophores/fluorophores and methods for using the same
|
CA2389317A1
(en)
|
1999-10-20 |
2001-04-26 |
Frederic J. De Sauvage |
Modulation of t cell differentiation for the treatment of t helper cell mediated diseases
|
AU784203B2
(en)
|
1999-10-29 |
2006-02-23 |
Glaxosmithkline Biologicals S.A. |
Neisserial antigenic peptides
|
US7078382B1
(en)
|
1999-11-02 |
2006-07-18 |
Genentech, Inc. |
Modulation of eNOS activity and therapeutic uses thereof
|
AU782918B2
(en)
|
1999-11-10 |
2005-09-08 |
University Of Washington |
Compositions and methods for modulation of plant cell division
|
AU2055401A
(en)
|
1999-12-01 |
2001-06-12 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU782067B2
(en)
|
1999-12-20 |
2005-06-30 |
Immunex Corporation |
TWEAK receptor
|
EP1897947B1
(en)
|
1999-12-23 |
2012-01-18 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
CA2395617C
(en)
|
1999-12-30 |
2012-10-30 |
Genencor International, Inc. |
Trichoderma reesei xylanase
|
ATE402258T1
(de)
|
2000-01-10 |
2008-08-15 |
Novartis Vaccines & Diagnostic |
Gene differentiell experimiert in brudtkrebs
|
ATE424457T1
(de)
|
2000-01-13 |
2009-03-15 |
Genentech Inc |
Menschliche stra6 polypeptide
|
EP2275129A3
(en)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
|
AU2001252958A1
(en)
|
2000-03-23 |
2001-10-03 |
Elan Pharmaceuticals, Inc. |
Compounds and methods to treat alzheimer's disease
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
WO2004043361A2
(en)
|
2002-11-08 |
2004-05-27 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
EP2792747A1
(en)
|
2000-06-23 |
2014-10-22 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
EP2168980A1
(en)
|
2000-06-23 |
2010-03-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogensis
|
ATE302751T1
(de)
|
2000-06-30 |
2005-09-15 |
Elan Pharm Inc |
Verbindungen zur behandlung der alzheimerischen krankheit
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
DE60136281D1
(de)
|
2000-08-24 |
2008-12-04 |
Genentech Inc |
Methode zur inhibierung von il-22 induziertem pap1
|
EP1944317A3
(en)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
MX357775B
(es)
|
2000-10-27 |
2018-07-20 |
J Craig Venter Inst Inc |
Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
WO2002081642A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
WO2002081639A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
WO2002081641A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
US7384775B2
(en)
|
2001-04-16 |
2008-06-10 |
Wyeth |
Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
KR100607612B1
(ko)
|
2001-06-20 |
2006-08-02 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
US6867189B2
(en)
|
2001-07-26 |
2005-03-15 |
Genset S.A. |
Use of adipsin/complement factor D in the treatment of metabolic related disorders
|
ATE469915T1
(de)
|
2001-07-27 |
2010-06-15 |
Novartis Vaccines & Diagnostic |
Antikörper gegen das meningokokken adhäsin app
|
MY144532A
(en)
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
PL368972A1
(en)
|
2001-08-29 |
2005-04-04 |
Genentech, Inc. |
Bv8 nucleic acids and polypeptides with mitogenic activity
|
EP2153843B1
(en)
|
2001-09-18 |
2012-08-15 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
ATE406912T1
(de)
|
2001-12-12 |
2008-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia tracheomatis
|
WO2003054158A2
(en)
|
2001-12-19 |
2003-07-03 |
The University Of Chicago |
Rapidly maturing fluorescent proteins and methods for using the same
|
US20030228305A1
(en)
|
2002-01-02 |
2003-12-11 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP2388265A1
(en)
|
2002-02-22 |
2011-11-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7138512B2
(en)
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
EP1571968A4
(en)
|
2002-04-16 |
2007-10-17 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS
|
WO2003099854A2
(en)
|
2002-05-24 |
2003-12-04 |
Nps Allelix Corp. |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
AU2003239865A1
(en)
|
2002-05-24 |
2003-12-12 |
Restoragen Inc. |
Method for universal enzymatic production of bioactive peptides
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
EP2430923A1
(en)
|
2002-06-05 |
2012-03-21 |
Genentech, Inc. |
Compositions and methods for liver growth and liver protection
|
JP2005528905A
(ja)
|
2002-06-07 |
2005-09-29 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
EP2383278A1
(en)
|
2002-07-08 |
2011-11-02 |
Genentech, Inc. |
Method to determine B cell mediated diseases
|
JP5401001B2
(ja)
|
2002-09-11 |
2014-01-29 |
ジェネンテック, インコーポレイテッド |
免疫関連疾患の治療のための新規組成物と方法
|
WO2004024072A2
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
EP2444409A2
(en)
|
2002-09-16 |
2012-04-25 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US20070042945A1
(en)
|
2002-09-25 |
2007-02-22 |
Genentech, Inc. |
Nouvelles compositions et methods de traitement du psoriasis
|
CN101914559B
(zh)
|
2002-10-04 |
2012-04-04 |
弗门尼舍有限公司 |
倍半萜烯合成酶及其使用方法
|
EP1576137A4
(en)
|
2002-10-29 |
2010-06-30 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM
|
AU2003288660A1
(en)
|
2002-11-15 |
2004-06-15 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
US20070048301A1
(en)
|
2002-11-26 |
2007-03-01 |
Bodary-Winter Sarah C |
Compositions and methods for the treatment of immune related diseases
|
JP4912144B2
(ja)
|
2003-03-12 |
2012-04-11 |
ジェネンテック, インコーポレイテッド |
造血促進のためのbv8及び/又はeg−vegfの使用
|
CN1798575A
(zh)
|
2003-04-04 |
2006-07-05 |
健泰科生物技术公司 |
高浓度抗体和蛋白制剂
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US7348420B2
(en)
|
2003-04-25 |
2008-03-25 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
|
EP2319863A1
(en)
|
2003-06-23 |
2011-05-11 |
North Carolina State University |
Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
|
PL2784084T3
(pl)
|
2003-07-08 |
2020-03-31 |
Genentech, Inc. |
Przeciwciała antagonistyczne wobec heterologicznych polipeptydów IL-17A/F
|
US7442785B2
(en)
|
2003-07-24 |
2008-10-28 |
The University Of Kentucky Research Foundation |
Sesquiterpene synthase gene and protein
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
EP1670947B1
(en)
|
2003-09-23 |
2015-04-01 |
University Of North Carolina At Chapel Hill |
Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin k epoxide reductase gene and warfarin dosage
|
JP4777251B2
(ja)
|
2003-10-14 |
2011-09-21 |
バクスター・インターナショナル・インコーポレイテッド |
ビタミンkエポキシド還元酵素複合体サブユニット1vkorc1、クマリンおよびその誘導体の治療標的
|
SI2161283T1
(sl)
|
2003-11-17 |
2014-10-30 |
Genentech, Inc. |
Sestavki, ki obsegajo protitelesa proti CD79b, konjugirana na sredstvo, ki inhibira rast, ali na citotoksično sredstvo, in postopki za zdravljenje tumorja hematopoetskega izvora
|
ME01366B
(me)
|
2003-11-21 |
2013-12-20 |
Nps Allelix Corp |
POSTUPAK ZA PROIZVODNJU PEPTIDA 2 NALIK NA GLUKAGON l NJIHOVIH ANALOGA
|
NZ548256A
(en)
|
2004-02-02 |
2010-02-26 |
Ambrx Inc |
Modified human four helical bundle polypeptides and their uses
|
US7459289B2
(en)
|
2004-03-08 |
2008-12-02 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
|
US8268324B2
(en)
|
2004-03-29 |
2012-09-18 |
Galpharma Co., Ltd. |
Modified galectin 9 proteins and use thereof
|
WO2005100387A1
(en)
|
2004-04-07 |
2005-10-27 |
The University Of Chicago |
Monomeric red fluorescent proteins
|
KR20070034512A
(ko)
|
2004-06-18 |
2007-03-28 |
암브룩스, 인코포레이티드 |
신규 항원-결합 폴리펩티드 및 이의 용도
|
AU2005333603A1
(en)
|
2004-10-21 |
2007-01-04 |
Wyeth |
Immunogenic compositions of Staphylococcus epidermidis polypeptide antigens
|
CA2927595C
(en)
|
2004-12-22 |
2023-01-31 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
CA2592390A1
(en)
|
2004-12-22 |
2006-06-29 |
Genentech, Inc. |
Methods for producing soluble multi-membrane-spanning proteins
|
CN103690936A
(zh)
|
2004-12-22 |
2014-04-02 |
Ambrx公司 |
经修饰的人类生长激素
|
EP1861499A4
(en)
|
2005-03-15 |
2008-09-03 |
Univ North Carolina |
METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ACTIVE PROTEINS DEPENDENT ON VITAMIN K
|
NZ561681A
(en)
|
2005-03-21 |
2011-01-28 |
Virobay Inc |
Alpha ketoamide compounds as cysteine protease inhibitors
|
AU2006236629B2
(en)
|
2005-04-15 |
2012-04-19 |
North Carolina State University |
Methods and compositions to modulate adhesion and stress tolerance in bacteria
|
ATE498631T1
(de)
|
2005-05-04 |
2011-03-15 |
Zealand Pharma As |
Glucagon-like-peptide-2- (glp-2-) analoga
|
ATE515512T1
(de)
|
2005-05-12 |
2011-07-15 |
Zymogenetics Inc |
Zusammensetzungen und verfahren zur modulierung von immunreaktionen
|
AU2006255686A1
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
EP2422615B1
(en)
|
2005-07-29 |
2014-06-18 |
Targeted Growth, Inc. |
Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp
|
CA2619577A1
(en)
|
2005-08-15 |
2007-02-22 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
EP3181575B1
(en)
|
2005-08-31 |
2021-03-17 |
The Regents of The University of California |
Cellular libraries of peptide sequences (clips) and methods of using the same
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
DE102005048898A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
|
IN2014DN06624A
(el)
|
2005-10-18 |
2015-07-10 |
Univ Colorado |
|
US7749704B2
(en)
|
2005-11-01 |
2010-07-06 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the BLyS gene and use in diagnostic methods
|
AU2006315347A1
(en)
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
US20090293137A1
(en)
|
2005-11-21 |
2009-11-26 |
Genentech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
US8026354B2
(en)
|
2005-11-23 |
2011-09-27 |
Institut Pasteur |
Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
ATE497973T1
(de)
|
2005-12-22 |
2011-02-15 |
Genentech Inc |
Rekombinante produktion heparinbindender proteine
|
US20080311107A1
(en)
|
2006-02-17 |
2008-12-18 |
Genetech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
EP2082645A1
(en)
|
2006-04-19 |
2009-07-29 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
WO2007127936A2
(en)
|
2006-04-27 |
2007-11-08 |
Pikamab, Inc. |
Methods and compositions for antibody therapy
|
DK2054431T3
(da)
|
2006-06-09 |
2012-01-02 |
Novartis Ag |
Konformere af bakterielle adhæsiner
|
EP2035572A4
(en)
|
2006-06-30 |
2010-01-06 |
Univ Michigan |
PROCESS FOR THE PREPARATION OF FACTOR VIII PROTEINS BY RECOMBINATION PROCEDURES
|
CA2663083A1
(en)
|
2006-09-08 |
2008-03-13 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and their uses
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
US20080254512A1
(en)
|
2006-11-02 |
2008-10-16 |
Capon Daniel J |
Hybrid immunoglobulins with moving parts
|
WO2008103962A2
(en)
|
2007-02-22 |
2008-08-28 |
Genentech, Inc. |
Methods for detecting inflammatory bowel disease
|
WO2008121563A2
(en)
|
2007-03-30 |
2008-10-09 |
Ambrx, Inc. |
Modified fgf-21 polypeptides and their uses
|
JP5511653B2
(ja)
|
2007-04-20 |
2014-06-04 |
シグマ−タウ レア ディジージズ エスィアー |
安定な組換えアデノシン・デアミナーゼ
|
EP2139499A4
(en)
|
2007-04-26 |
2010-05-05 |
Inspiration Biopharmaceuticals |
RECOMBINANT VITAMIN K-DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHOD FOR THE PRODUCTION THEREOF
|
CN111499748A
(zh)
|
2007-07-16 |
2020-08-07 |
健泰科生物技术公司 |
抗cd79b抗体和免疫偶联物及使用方法
|
PE20090481A1
(es)
|
2007-07-16 |
2009-05-18 |
Genentech Inc |
Anticuerpos anti-cd79b e inmunoconjugados humanizados y metodos de uso
|
WO2009014726A1
(en)
|
2007-07-26 |
2009-01-29 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗脂肪肝中的应用
|
AU2008308509B2
(en)
|
2007-10-04 |
2014-10-23 |
Zymogenetics, Inc. |
B7 family member zB7H6 and related compositions and methods
|
US20090233990A1
(en)
|
2007-11-01 |
2009-09-17 |
Hee Cheol Cho |
Generation of biological pacemaker activity
|
US8679749B2
(en)
|
2007-11-01 |
2014-03-25 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
NZ603812A
(en)
|
2007-11-20 |
2014-06-27 |
Ambrx Inc |
Modified insulin polypeptides and their uses
|
WO2009070648A2
(en)
|
2007-11-27 |
2009-06-04 |
Medtronic, Inc. |
Humanized anti-amyloid beta antibodies
|
US8003325B2
(en)
|
2007-11-30 |
2011-08-23 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the BLyS gene and use in diagnostic methods
|
EP3269737B1
(en)
|
2008-01-31 |
2024-06-19 |
Genentech, Inc. |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
CN103694337B
(zh)
|
2008-02-08 |
2016-03-02 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
EP3263591B1
(en)
|
2008-02-21 |
2019-03-27 |
GlaxoSmithKline Biologicals S.A. |
Meningococcal fhbp polypeptides
|
KR101855381B1
(ko)
|
2008-04-09 |
2018-05-09 |
제넨테크, 인크. |
면역 관련 질병의 치료를 위한 신규한 조성물 및 방법
|
CA2723114C
(en)
|
2008-05-16 |
2018-02-27 |
Taiga Biotechnologies, Inc. |
Antibodies and processes for preparing the same
|
EP3225248B1
(en)
|
2008-07-23 |
2023-06-07 |
Ambrx, Inc. |
Modified bovine g-csf polypeptides and their uses
|
WO2010025421A2
(en)
|
2008-08-28 |
2010-03-04 |
Taiga Biotechnologies, Inc. |
Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
|
CA2737026C
(en)
|
2008-09-26 |
2019-12-24 |
Ambrx, Inc. |
Modified animal erythropoietin polypeptides and their uses
|
CA2738033C
(en)
|
2008-09-26 |
2019-11-26 |
Ambrx, Inc. |
Non-natural amino acid replication-dependent microorganisms and vaccines
|
US9702877B2
(en)
|
2008-10-31 |
2017-07-11 |
Quest Diagnostics Investments Incorporated |
BCR-ABL variants
|
CN102292101A
(zh)
|
2008-11-26 |
2011-12-21 |
五佳医疗股份有限公司 |
通过serpine2来调节胶原和平滑肌肌动蛋白表达的组合物和方法
|
WO2010091122A1
(en)
|
2009-02-03 |
2010-08-12 |
Amunix, Inc. |
Extended recombinant polypeptides and compositions comprising same
|
JP6132548B2
(ja)
|
2009-04-01 |
2017-05-24 |
ジェネンテック, インコーポレイテッド |
抗FcRH5抗体および免疫接合体および使用方法
|
EP2251025A1
(en)
|
2009-05-12 |
2010-11-17 |
Universitat Autònoma De Barcelona |
Use of inclusion bodies as therapeutic agents
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
AU2010258898B8
(en)
|
2009-06-08 |
2015-02-05 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
EA030619B1
(ru)
|
2009-06-08 |
2018-09-28 |
Амуникс Оперейтинг Инк. |
Гибридный белок, включающий последовательности гормона роста и xten, способ его получения и применения
|
JP5946766B2
(ja)
|
2009-07-03 |
2016-07-06 |
ビオノール イミュノ エーエスBionor Immuno As |
Hivワクチン組成物における使用又は診断手段としての使用のためのhiv関連ペプチドの組合せ又は融合物
|
US20120263701A1
(en)
|
2009-08-24 |
2012-10-18 |
Volker Schellenberger |
Coagulation factor vii compositions and methods of making and using same
|
EP2470204B1
(en)
|
2009-08-27 |
2015-12-16 |
GlaxoSmithKline Biologicals SA |
Hybrid polypeptides including meningococcal fhbp sequences
|
WO2011041308A1
(en)
|
2009-09-30 |
2011-04-07 |
Quest Diagnostics Investments Incorporated |
Bcr-abl truncation mutations
|
EP2486131A1
(en)
|
2009-10-06 |
2012-08-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Carbapenemase and antibacterial treatment
|
EP2488643A4
(en)
|
2009-10-15 |
2013-07-03 |
Hoffmann La Roche |
CHIMERIC FIBROBLAST GROWTH FACTORS WITH CHANGED RECEPTOR SPECIFICITY
|
CN102711826B
(zh)
|
2009-10-22 |
2017-03-29 |
霍夫曼-拉罗奇有限公司 |
用于调控巨噬细胞刺激性蛋白的hepsin活化的方法和组合物
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
MX2012004850A
(es)
|
2009-10-27 |
2012-05-22 |
Novartis Ag |
Polipeptidos fhbp meningococicos modificados.
|
WO2011060246A2
(en)
|
2009-11-12 |
2011-05-19 |
Genentech, Inc. |
A method of promoting dendritic spine density
|
PE20121584A1
(es)
|
2009-11-30 |
2012-11-29 |
Genentech Inc |
Composiciones y metodos para el diagnostico y el tratamiento de tumores
|
MX349301B
(es)
|
2009-12-21 |
2017-07-21 |
Ambrx Inc |
Polipéptidos de somatotropina bovina modificados y sus usos.
|
CN104017063A
(zh)
|
2009-12-21 |
2014-09-03 |
Ambrx公司 |
经过修饰的猪促生长素多肽和其用途
|
FR2954349A1
(fr)
|
2009-12-22 |
2011-06-24 |
Agronomique Inst Nat Rech |
Sulfatase modifiant selectivement les glycosaminoglycanes
|
AR080243A1
(es)
|
2010-02-23 |
2012-03-21 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores
|
EP2552967A4
(en)
|
2010-04-02 |
2014-10-08 |
Amunix Operating Inc |
BINDING FUSION PROTEINS, BINDING FUSION PROTEIN MEDICINAL CONJUGATES, XTEN MEDICAMENT CONJUGATES, AND METHOD FOR THEIR PREPARATION AND USE
|
MA34291B1
(fr)
|
2010-05-03 |
2013-06-01 |
Genentech Inc |
Compositions et méthodes de diagnostic et de traitement d'une tumeur
|
EP2571894A1
(en)
|
2010-05-19 |
2013-03-27 |
North Carolina State University |
Compositions and methods for the delivery of therapeutic peptides
|
WO2011149461A1
(en)
|
2010-05-27 |
2011-12-01 |
Medtronic, Inc. |
Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
|
KR101768118B1
(ko)
|
2010-06-25 |
2017-08-14 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
기도 감염의 치료를 위한 방법 및 약학 조성물
|
EP2598526B1
(en)
|
2010-07-29 |
2018-09-05 |
Eleven Biotherapeutics, Inc. |
Chimeric il-1 receptor type i agonists and antagonists
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
DK2605789T3
(da)
|
2010-08-17 |
2019-09-16 |
Ambrx Inc |
Modificerede relaxinpolypeptider og anvendelser deraf
|
EP2420253A1
(en)
|
2010-08-20 |
2012-02-22 |
Leadartis, S.L. |
Engineering multifunctional and multivalent molecules with collagen XV trimerization domain
|
US8846890B2
(en)
|
2010-08-30 |
2014-09-30 |
Board Of Trustees Of Michigan State University |
Microbial nanowires
|
CN102380091A
(zh)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
CA2811403A1
(en)
|
2010-09-15 |
2012-03-22 |
Aligna Technologies, Inc. |
Bioproduction of aromatic chemicals from lignin-derived compounds
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
EP2441776A1
(en)
|
2010-10-15 |
2012-04-18 |
Leadartis, S.L. |
Generation of multifunctional and multivalent polypeptide complexes with collagen XVIII trimerization domain
|
EP2646465B1
(en)
|
2010-10-15 |
2018-09-12 |
Leadartis, S.L. |
Generation of multifunctional and multivalent polypeptide complexes with collagen xviii trimerization domain
|
WO2012088222A2
(en)
|
2010-12-21 |
2012-06-28 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin k-dependent proteins
|
US8603740B2
(en)
|
2010-12-29 |
2013-12-10 |
Quest Diagnostics Investments Incorporated |
BCR-ABL1 splice variants and uses thereof
|
WO2012095684A1
(en)
|
2011-01-10 |
2012-07-19 |
Inserm ( Institut National De La Sante Et De La Recherche Medicale) |
Methods for the screening of substances useful for the prevention and treatment of neisseria infections
|
WO2012103240A2
(en)
|
2011-01-25 |
2012-08-02 |
Eleven Biotherapeutics, Inc. |
Receptor binding agents
|
JP5977814B2
(ja)
|
2011-04-08 |
2016-08-24 |
アムジエン・インコーポレーテツド |
増殖分化因子15(gdf−15)を使用して代謝障害を治療または改善する方法
|
WO2013011072A1
(en)
|
2011-07-20 |
2013-01-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Carbapenemase and antibacterial treatment
|
WO2013019652A1
(en)
|
2011-07-29 |
2013-02-07 |
Eleven Biotherapeutics, Inc. |
Purified proteins
|
WO2013033456A2
(en)
|
2011-09-02 |
2013-03-07 |
Board Of Trustees Of Michigan State University |
Microbial nanowires and methods of making and using
|
BR112014018575A2
(pt)
|
2012-01-26 |
2017-07-04 |
Amgen Inc |
polipetídeos de fator de diferenciação de crescimento 15 (gdf-15)
|
LT2814840T
(lt)
|
2012-02-15 |
2020-02-25 |
Bioverativ Therapeutics Inc. |
Faktoriaus viii kompozicijos ir jų gavimo ir naudojimo būdai
|
EP2822577B1
(en)
|
2012-02-15 |
2019-02-06 |
Bioverativ Therapeutics Inc. |
Recombinant factor viii proteins
|
WO2013130683A2
(en)
|
2012-02-27 |
2013-09-06 |
Amunix Operating Inc. |
Xten conjugate compositions and methods of making same
|
US20140080180A1
(en)
|
2012-03-27 |
2014-03-20 |
Genentech, Inc. |
Harvest operations for recombinant proteins
|
DK2841087T3
(da)
|
2012-04-27 |
2017-11-20 |
Us Health |
Vaskulær endothel-vækstfaktor-antagonister og fremgangsmåder til anvendelse deraf
|
MX356958B
(es)
|
2012-05-03 |
2018-06-20 |
Zealand Pharma As |
Análogos de péptido-2 tipo glucagón (glp-2).
|
WO2013182660A1
(en)
|
2012-06-06 |
2013-12-12 |
Bionor Immuno As |
Hiv vaccine
|
DK2877189T3
(da)
|
2012-07-20 |
2021-02-22 |
Taiga Biotechnologies Inc |
Forbedret rekonstituering og autorekonstituering af det hæmopoietiske kammer
|
WO2014026136A2
(en)
|
2012-08-10 |
2014-02-13 |
Cytomx Therapeutics, Inc. |
Protease-resistant systems for polypeptide display and methods of making and using thereof
|
EP2922871B1
(en)
|
2012-11-20 |
2019-06-19 |
The University of North Carolina At Chapel Hill |
Methods and compositions for modified factor ix proteins
|
US9879245B2
(en)
|
2012-12-07 |
2018-01-30 |
Danisco Us Inc. |
Polypeptides having beta-mannanase activity and methods of use
|
WO2014088934A1
(en)
|
2012-12-07 |
2014-06-12 |
Danisco Us Inc. |
Compositions and methods of use
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
DK2968468T3
(en)
|
2013-03-13 |
2021-07-26 |
Buzzard Pharmaceuticals AB |
Chimeric cytokine formulations for ocular delivery
|
DK3611180T3
(da)
|
2013-03-15 |
2022-02-28 |
Biomolecular Holdings Llc |
Hybrid immunoglobulin indeholdende ikke-peptidyl-binding
|
SG11201507429TA
(en)
|
2013-03-15 |
2015-10-29 |
Genentech Inc |
Il-22 polypeptides and il-22 fc fusion proteins and methods of use
|
WO2015007337A1
(en)
|
2013-07-19 |
2015-01-22 |
Bionor Immuno As |
Method for the vaccination against hiv
|
EP3033097B1
(en)
|
2013-08-14 |
2021-03-10 |
Bioverativ Therapeutics Inc. |
Factor viii-xten fusions and uses thereof
|
WO2015059690A1
(en)
|
2013-10-24 |
2015-04-30 |
Yeda Research And Development Co. Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using s ame
|
RU2016117275A
(ru)
|
2013-11-01 |
2017-12-04 |
Сфериум Биомед С.Л. |
Тельца включения для трансдермальной доставки терапевтических и косметических средств
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
SG10201807877TA
(en)
|
2014-03-14 |
2018-10-30 |
Daniel Capon |
Hybrid immunoglobulin containing non-peptidyl linkage
|
EP3166633A1
(en)
|
2014-07-11 |
2017-05-17 |
Bionor Immuno AS |
Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)
|
US20170233707A1
(en)
|
2014-09-30 |
2017-08-17 |
Danisco Us Inc |
Compositions comprising beta-mannanase and methods of use
|
US20170211054A1
(en)
|
2014-09-30 |
2017-07-27 |
Dansico Us Inc. |
Compositions comprising beta mannanase and methods of use
|
EP3201332A1
(en)
|
2014-09-30 |
2017-08-09 |
Danisco US Inc. |
Compositions comprising beta-mannanase and methods of use
|
US20170211053A1
(en)
|
2014-09-30 |
2017-07-27 |
Danisco Us Inc. |
Compositions comprising beta mannanase and methods of use
|
EP3201333A1
(en)
|
2014-09-30 |
2017-08-09 |
Danisco US Inc. |
Compositions comprising beta-mannanase and methods of use
|
MX2017004947A
(es)
|
2014-10-24 |
2017-06-29 |
Bristol Myers Squibb Co |
Polipeptidos del factor de crecimiento de fibroblastos 2 (fgf-21) modificados y usos de los mismos.
|
WO2016100825A1
(en)
|
2014-12-18 |
2016-06-23 |
Danisco Us Inc |
Engineered multifunctional enzymes and methods of use
|
EP3234119A1
(en)
|
2014-12-18 |
2017-10-25 |
Danisco US Inc. |
Engineered multifunctional enzymes and methods of use
|
EP3253786A4
(en)
|
2015-02-06 |
2018-10-17 |
The University of North Carolina at Chapel Hill |
Optimized human clotting factor viii gene expression cassettes and their use
|
JP6740244B2
(ja)
|
2015-03-31 |
2020-08-12 |
ノビミューン エスアー |
ヘテロ多量体タンパク質複合体のアセンブリおよび産生を最適化する方法
|
CA2984991A1
(en)
|
2015-05-04 |
2016-11-10 |
Bionor Immuno As |
Dosage regimen for hiv vaccine
|
AU2016301303B2
(en)
|
2015-08-03 |
2021-10-07 |
Bioverativ Therapeutics Inc. |
Factor IX fusion proteins and methods of making and using same
|
EP4129327A1
(en)
|
2015-08-28 |
2023-02-08 |
Amunix Pharmaceuticals, Inc. |
Chimeric polypeptide assembly and methods of making and using the same
|
JP2019510517A
(ja)
|
2016-03-29 |
2019-04-18 |
ジェルター, インコーポレイテッド |
細胞質内体積に対するペリプラズム体積の比率が0.5:1および10:1の間にあるグラム陰性細菌におけるタンパク質の発現
|
CN109328069B
(zh)
|
2016-04-15 |
2023-09-01 |
亿一生物医药开发(上海)有限公司 |
Il-22在治疗坏死性小肠结肠炎中的用途
|
US10590426B2
(en)
|
2016-08-22 |
2020-03-17 |
Board Of Trustees Of Michigan State University |
Genetic control of cell size
|
IL281425B
(en)
|
2016-12-02 |
2022-07-01 |
Taiga Biotechnologies Inc |
Nanoparticle formulations
|
JP2020513410A
(ja)
|
2016-12-06 |
2020-05-14 |
カレイド・バイオサイエンシズ・インコーポレイテッド |
グリカンポリマーおよびその関連方法
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
KR102670432B1
(ko)
|
2017-02-08 |
2024-05-28 |
브리스톨-마이어스 스큅 컴퍼니 |
약동학적 인핸서를 포함하는 변형된 렐락신 폴리펩티드 및 그의 용도
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
EP4026554A1
(en)
|
2017-08-03 |
2022-07-13 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|
US11180541B2
(en)
|
2017-09-28 |
2021-11-23 |
Geltor, Inc. |
Recombinant collagen and elastin molecules and uses thereof
|
EP3743437A1
(en)
|
2018-01-26 |
2020-12-02 |
F. Hoffmann-La Roche AG |
Il-22 fc fusion proteins and methods of use
|
DK3743088T3
(da)
|
2018-01-26 |
2022-12-19 |
Hoffmann La Roche |
IL-22 Fc-sammensætninger og fremgangsmåder til anvendelse
|
CA3091139A1
(en)
|
2018-02-21 |
2019-08-29 |
Genentech, Inc. |
Dosing for treatment with il-22 fc fusion proteins
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
AU2019253462A1
(en)
|
2018-04-09 |
2020-11-26 |
Amgen Inc. |
Growth differentiation factor 15 fusion proteins
|
AU2019270184A1
(en)
|
2018-05-18 |
2020-11-26 |
Bioverativ Therapeutics Inc. |
Methods of treating hemophilia A
|
EP3802601A1
(en)
|
2018-06-06 |
2021-04-14 |
Leadartis, S.L. |
Trimeric polypeptide complexes and uses thereof
|
KR20210057124A
(ko)
|
2018-09-11 |
2021-05-20 |
암브룩스, 인코포레이티드 |
인터류킨-2 폴리펩타이드 접합체 및 그의 용도
|
EP3946611A2
(en)
|
2019-03-31 |
2022-02-09 |
Yeda Research and Development Co. Ltd |
Anti-viral and anti-tumoral compounds
|
WO2020210440A1
(en)
|
2019-04-12 |
2020-10-15 |
Geltor, Inc. |
Recombinant elastin and production thereof
|
KR102134418B1
(ko)
*
|
2019-06-17 |
2020-07-16 |
씨제이제일제당 주식회사 |
L-타이로신을 생산하는 미생물 및 이를 이용한 l-타이로신 생산 방법
|
CN115243726A
(zh)
|
2020-03-11 |
2022-10-25 |
北京泰德制药股份有限公司 |
白介素-2多肽偶联物及其使用方法
|
WO2021207662A1
(en)
|
2020-04-10 |
2021-10-14 |
Genentech, Inc. |
Use of il-22fc for the treatment or prevention of pneumonia, acute respiratory distress syndrome, or cytokine release syndrome
|
IL288680A
(en)
|
2021-12-05 |
2023-07-01 |
Yeda Res & Dev |
Genetically modified phages and their use
|
WO2024133316A1
(en)
|
2022-12-23 |
2024-06-27 |
Thermo Fisher Scientific Baltics Uab |
Closed system for expressing recombinant proteins using e. coli and methods for producing clarified cell cultures thereof
|